Abstract |
Killing tumor cells with a visualized system is a promising strategy in tumor therapy to achieve minimal side effects and high efficiency. Herein, a theranostic nanomedicine (AuNCs-Pt) is developed based on nanocarrier gold nanoclusters (AuNCs) with bifunctions of both NIR-I/NIR-II imaging and glutathione-scavenging abilities. AuNCs-Pt possesses NIR-II imaging capability on a fatal high-grade serous ovarian cancer (HGSOC) model in the deep abdomen, thus facilitating it to be a promising tool for monitoring platinum transportation. Meanwhile, AuNCs-Pt depletes intracellular glutathione to minimize platinum detoxification, effectively maximizing the chemotherapeutic efficacy of platinum. AuNCs-Pt is used to eradicate the tumor burden in this study on a HGSOC model and a patient-derived tumor xenograft model of hepatocellular carcinoma, suggesting great potential for clinical visualized therapy and platinum drug sensitization.
|
Authors | Yuanyuan Yang, Yingjie Yu, Hao Chen, Xiangxi Meng, Wen Ma, Meng Yu, Ziyuan Li, Changhui Li, Haile Liu, Xiaodong Zhang, Haihua Xiao, Zhiqiang Yu |
Journal | ACS nano
(ACS Nano)
Vol. 14
Issue 10
Pg. 13536-13547
(10 27 2020)
ISSN: 1936-086X [Electronic] United States |
PMID | 32924505
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Platinum
- Gold
- Glutathione
|
Topics |
- Glutathione
- Gold
- Humans
- Liver Neoplasms
- Metal Nanoparticles
- Platinum
- Theranostic Nanomedicine
|